Neurocrine Biosciences, Inc. · NASDAQ:NBIX
Norwalk Leslie V sold 1,250 Neurocrine Biosciences, Inc. shares (Form 4)
Traded Jul 28 to Jul 29, 2026 · Filed Jul 30, 2026
From Jul 28 to Jul 29, 2026, Norwalk Leslie V (Director) sold 1,250 Neurocrine Biosciences, Inc. shares at US$182.01 for US$228K under a trading plan, leaving 2,430 shares. Filed Jul 30, 2026 (Form 4).
- Sold
- 1,250 shares
- Price
- US$182.01
- Value
- US$228K
- Holding after
- 2,430 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 28, 2026 | Common Stock | Sale | 1,250 | US$182.01 | 1,588 | Direct |
| Jul 29, 2026 | Common Stock | Option exercise | 842 | US$139.43 | 2,430 | Direct |
Source
Related
- Neurocrine Biosciences, Inc.
- Norwalk Leslie V
- Neurocrine Biosciences, Inc. shareholders
- Form 4 · Norwalk Leslie V · Jun 8, 2026
- Form 4 · Norwalk Leslie V · May 21, 2026
- Form 4 · Norwalk Leslie V · May 14, 2026
- Schedule 13G/A · JPMorgan Chase & Co · Oct 15, 2026
- Form 4 · Boyer David W. · Sep 15, 2026
- Form 4 · Abernethy Matt · Sep 15, 2026
- Form 4 · Gano Kyle · Sep 15, 2026
- Form 4 · Onyia Jude · Sep 15, 2026